UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044685
Receipt number R000051035
Scientific Title Predictive Refraction Accuracy of the ORA Intraoperative Wavefront Aberration Analyzer for PanOptix (non-Toric) and PanOptix Toric
Date of disclosure of the study information 2021/06/28
Last modified on 2021/06/28 14:55:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Predictive Refractive Accuracy of Intraoperative Wavefront Aberration Analyzer for Trifocal IOLs

Acronym

Predictive Refractive Accuracy of Intraoperative Wavefront Aberration Analyzer for Trifocal IOLs

Scientific Title

Predictive Refraction Accuracy of the ORA Intraoperative Wavefront Aberration Analyzer for PanOptix (non-Toric) and PanOptix Toric

Scientific Title:Acronym

Predictive Refraction Accuracy of the ORA Intraoperative Wavefront Aberration Analyzer for PanOptix (non-Toric) and PanOptix Toric

Region

Japan


Condition

Condition

Cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In recent years, cataract surgery has made remarkable progress, and expectations of patients have been growing for the surgery. The patients especially have higher expectations for Premium IOLs in terms of its property and those need higher accuracy of the preoperative examination and the IOL power calculation.
ORA, an intraoperative wavefront aberrometry, enables surgeons to measure the refraction in the aphakic phase and determine the IOL power intraoperatively, and ORA has been reported that it has the same or higher accuracy of predicted postoperative refraction as the preoperative IOL power formulas. On the other hand, PanOptix is the first approved trifocal intraocular lens in Japan, and it is reported that PanOptix shows good visual performance and satisfaction. Although further improvements in accuracy and satisfaction can be expected by using ORA, there is few reports to have assessed the predictive accuracy of ORA with PanOptix.
Not only spherical equivalent refractive errors but also residual astigmatism highly influence on the postoperative satisfactions. We have experienced some cases, in which the preoperative examination indicated the adaption of non-Toric IOL but the residual astigmatism remained after the surgery, and Toric IOL should have been inserted. Thus, it is desirable to be able to choose Toric or non-Toric and determine the cylindrical power of Toric IOL before the IOL insertion. Therefore, we decided to conduct a retrospective study to compare ORA with the preoperative IOL power calculation formulas in the predictive accuracy for PanOptix and PanOptix Toric, and also to investigate correlation between the postoperative residual astigmatism and each factor.

Basic objectives2

Others

Basic objectives -Others

The predictive refractive accuracy of ORA for PanOptix (non-Toric) and PanOptix Toric will be evaluated in comparison to preoperative IOL power calculations. In addition, factors associated with postoperative residual astigmatism will be investigated.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ORA and preoperative IOL power formula and the equivalent spherical power of subjective refraction at 1 to 3 months postoperatively

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients who have underwent cataract surgery by phacoemulsification in Minami Osaka Eye Clinic and have the data of examination and observation criteria
(2) Patients with PanOptix or PanOptix Toric inserted in the capsular bag
(3) Postoperative Best Corrected Distance visual acuity (BCDVA) of 1.0 decimal or better in study eye
(4) Patients who have performed intraoperative refractive biometry measurement with ORA
(5) The age of 20 and more

Key exclusion criteria

(1) Patients with the experience of ocular surgery other than cataract surgery within 3 months after cataract surgery
(2) Patients with corneal lesion affecting the measurement of ORA during surgery
(3) Patients where ORA measurement was poor
(4) Patients with a disease possibly affecting the visual acuity or patients receiving medication possibly affecting the visual acuity
(5) Patients found during surgery to have laceration of zonule of Zinn, posterior capsule rupture, vitreous loss, hyphema or inability to implant the IOL in the capsular bag completely.
(6) Disqualified by the investigator or the sub investigator because of systemic or ophthalmic diseases

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Keizo
Middle name
Last name Watanabe

Organization

Minami Osaka Eye Clinic

Division name

Minami Osaka Eye Clinic

Zip code

5900402

Address

3-174-6, Okubokita, Kumatori-cho, Sennan-gun, Osaka, Japan

TEL

072-453-1750

Email

nabedosu@outlook.com


Public contact

Name of contact person

1st name Keizo
Middle name
Last name Watanabe

Organization

Minami Osaka Eye Clinic

Division name

Minami Osaka Eye Clinic

Zip code

5900402

Address

3-174-6, Okubokita, Kumatori-cho, Sennan-gun, Osaka, Japan

TEL

072-453-1750

Homepage URL


Email

nabedosu@outlook.com


Sponsor or person

Institute

Minami Osaka Eye Clinic

Institute

Department

Personal name



Funding Source

Organization

Alcon Japan Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NPO MINS

Address

1-15-14 Dogenzaka, Shibuya-ku, Tokyo

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

180

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 12 Month 17 Day

Date of IRB

2020 Year 12 Month 17 Day

Anticipated trial start date

2020 Year 12 Month 18 Day

Last follow-up date

2021 Year 06 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective single center observational study.
Information from patients who received the study site between July 2019 and December 2020 and met the selection exclusion criteria will be included.
The information to be included will be gender, age, comorbidities, treatment details, visual acuity test, biometric test, and refraction test.Retrospective single center observational study.
Information from patients who received the study site between July 2019 and December 2020 and met the selection exclusion criteria will be included.
The information to be included will be gender, age, comorbidities, treatment details, visual acuity test, biometric test, and refraction test.


Management information

Registered date

2021 Year 06 Month 28 Day

Last modified on

2021 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051035


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name